Metrics as of 10/14/2026, 06:54 PM (Berlin time), refresh in progress.
Alpha Tau Medical Stock
Alpha Tau Medical Ltd
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Israel
- CEO
- Uzi Sofer
- Employees
- 121
- Market cap
- $1.2 B
- IPO
- 08/03/2021
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on the research, development, and commercialization of diffusing alpha-emitters radiation therapy, known as Alpha DaRT, for the treatment of solid cancer. The Alpha-DaRT technology is currently undergoing clinical trials for various forms…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Alpha Tau Medical stock: price history
1D
-1.2%
1W
-4.7%
1M
-5.7%
6M
+72.3%
YTD
+174.2%
1Y
+241.9%
2Y
+525.6%
5Y
+37.3%
10Y
–
Next earnings date
Next earnings date
19/11/2026 (in 33 days)
Volatility around earnings
~19% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 14/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Alpha Tau Medical stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Average business model without a clear megatrend link or with mixed signals.
Alpha Tau Medical Ltd is an oncology company focused on the research and development of radiotherapy solutions. The core of the company is the so-called Alpha-DaRT technology, which utilizes diffusion-based alpha radiation for the treatment of solid tumors. The company is in the clinical phase and is currently conducting studies for various cancer types including skin, oral cavity, pancreatic, prostate, lung, liver and breast cancer, as well as preclinical investigations. The focus is on the subsequent commercialization of these therapeutic approaches.
- Revenue model
- Transactional
- Recurring revenue
- None
- Pricing power
- Weak
- Moat
- Narrow
- Moat type
- Regulatory
- Capital intensity
- High
- Customer concentration
- Unknown
Ask the agents about Alpha Tau Medical
Analyst assessment of Alpha Tau Medical
PRICE TARGET LOW
US$8.00
CONSENSUS
US$18.00
MEDIAN
US$16.00
PRICE TARGET HIGH
US$30.00
0
STRONG BUY
5
BUY
1
HOLD
0
SELL
0
STRONG SELL
6
TOTAL · Buy
As of: 03/09/2026
Alpha Tau Medical stock metrics
P/E
-13.05
P/B
28.02
EV/EBITDA
-24.82
RETURN ON EQUITY
-104.0%
NET MARGIN
0.0%
DEBT/EQUITY
0.34
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
68.6%
FLOAT SHARES
61,991,537
AVG. DAILY VOLUME (30D)
471,394
Insider transactions (SEC)
Levy Raphi
Levy Raphi
Levy Raphi
Levy Raphi
Levy Raphi
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.2%
Forums (Reddit)
See the full forum history with Pro.
Institutional holders
Comparable stocks
Frequently asked questions about Alpha Tau Medical stock
What does Alpha Tau Medical do?
Alpha Tau Medical Ltd is a company in the Healthcare sector, Biotechnology industry, headquartered in Israel.
The CEO is Uzi Sofer, the company employs around 121 people.
The IPO was on 08/03/2021; the stock trades on NASDAQ under the ticker DRTS.
What do analysts say about Alpha Tau Medical stock?
6 analysts rate the stock, the consensus is Buy (as of 03/09/2026).
The average price target is US$18.00, ranging from US$8.00 to US$30.00, with a median of US$16.00.
This is an external assessment, not a statement by Market Jury.
When does Alpha Tau Medical report next?
The next earnings date is 19/11/2026.
Around past earnings, price swings were roughly 19% stronger than usual.
Does Alpha Tau Medical pay a dividend?
No, Alpha Tau Medical currently does not pay a dividend.
Which stocks are comparable to Alpha Tau Medical?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines, Incyte and Genmab A/S.
How can I get Alpha Tau Medical stock analyzed?
Clicking "Analyze stock" lets five strategies assess Alpha Tau Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.